GET THE APP

Drug Designing: Open Access

Drug Designing: Open Access
Open Access

ISSN: 2169-0138

+44 1223 790975

Drug Designing: Open Access : Citations & Metrics Report

Articles published in Drug Designing: Open Access have been cited by esteemed scholars and scientists all around the world. Drug Designing: Open Access has got h-index 9, which means every article in Drug Designing: Open Access has got 9 average citations.

Following are the list of articles that have cited the articles published in Drug Designing: Open Access.

  2021 2020 2019 2018 2017 2016

Year wise published articles

31 67 2 5 16 18

Year wise citations received

50 43 38 38 22 46
Journal total citations count 368
Journal impact factor 1.70
Journal 5 years impact factor 1.5
Journal cite score 1.57
Journal h-index 9
Journal h-index since 2018 7
Important citations (297)

Ast dissolving drug delivery system: a review 2015

Fast dissolving drug delivery system: a review

Transgenic plants: resistance to abiotic and biotic stresses

Nano drug delivery system - a mini review

Potent biological agent benzimidazole–a review

Studies on drug switchability showed heterogeneity in methodological approaches: a scoping review.

On the glycosylation aspects of biosimilarity

Drugs acting on blood coagulation system and theirmechanism of action: a review

Quality assurance & quality control in laboratories: a review

Potential therapeutic targets and the role of technology in developing novel cannabinoid drugs from cyanobacteria.

Stem cell research therapy for neurodegenerative disorders- in what way to make it work

Impaired glucose metabolism in alzheimer's disease and diabetes

Current challenges to overcome in the management of type 2 diabetes mellitus and associated neurological disorders.

Incorporating a monofluoroalkene into the backbones of short peptides: evaluating the impact on local hydrophobicity.

Total quality system breakdowns in outsourced clinical trials

Outsourcing clinical trials outside of the us

The free radical theory of aging matures

Apoe-directed therapeutics rapidly clear ?-amyloid and reverse deficits in ad mouse models.

Mitochondrial diseases in man and mouse

Three structural features of functional food components and herbal medicine with amyloid ?42 anti-aggregation properties.

Top